| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/24/2003 | WO2003033673A2 High-throughput transcriptome and functional validation analysis |
| 04/24/2003 | WO2003033672A2 Nr3b nmda receptor subunit compositions and related methods |
| 04/24/2003 | WO2003033670A2 Method for preparation of single chain antibodies |
| 04/24/2003 | WO2003033668A2 Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis |
| 04/24/2003 | WO2003033664A2 Bone anti-resorptive compounds |
| 04/24/2003 | WO2003033663A2 Rankl mimics and uses thereof |
| 04/24/2003 | WO2003033660A2 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 04/24/2003 | WO2003033657A2 Antisense antiviral agent and method for treating ssrna viral infection |
| 04/24/2003 | WO2003033653A2 Affinity enhancement agents |
| 04/24/2003 | WO2003033648A2 Imaging the activity of extracellular proteases in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases |
| 04/24/2003 | WO2003033646A2 Compositions and methods for the modulation of viral maturation |
| 04/24/2003 | WO2003033539A1 Composition for polymerising immobilisation of biological molecules and method for producing said composition |
| 04/24/2003 | WO2003033513A1 Differentially expressed genes associated with obesity and type 2 diabetes |
| 04/24/2003 | WO2003033437A2 A method of forming neuraminidase inhibitors by dynamic combinatorial chemistry and compounds obtained |
| 04/24/2003 | WO2003033394A1 Container uncapping apparatus and method |
| 04/24/2003 | WO2003033149A2 Systems and methods for performing multiple diagnostic tests |
| 04/24/2003 | WO2003033009A2 Novel drug targets for arthritis |
| 04/24/2003 | WO2003033003A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator |
| 04/24/2003 | WO2003032923A2 Induction of beta cell differentiation in human cells |
| 04/24/2003 | WO2003032814A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 04/24/2003 | WO2003032813A2 Methods for the treatment of carcinoma |
| 04/24/2003 | WO2003032810A2 Treatment and diagnosis of insulin resistant states |
| 04/24/2003 | WO2003032809A2 Modulation of akt-dependent response to prevent restenosis |
| 04/24/2003 | WO2003006987A9 Methods and compositions for determining enzymatic activity and specificity of methyltransferases |
| 04/24/2003 | WO2003006643A3 A p387l variant in protein tyrosine phosphatase-1b is associated with type 2 diabetes and impaired serine phosphorylation of ptp-1b in vitro |
| 04/24/2003 | WO2003006614A3 UBE2s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 04/24/2003 | WO2003004699A3 Method for identifying nucleic acid molecules amplified in a polymerase chain reaction |
| 04/24/2003 | WO2003002975A3 Biophotonic sensors and methods of use thereof |
| 04/24/2003 | WO2002099387A3 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 04/24/2003 | WO2002098907A3 Cation conducting gabaa receptors and their use |
| 04/24/2003 | WO2002094777A3 Methods of detecting protein arginine methyltransferase, and uses related thereto |
| 04/24/2003 | WO2002093162A3 Individualization of therapy with antibiotic agents |
| 04/24/2003 | WO2002088343A3 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT) |
| 04/24/2003 | WO2002088180A3 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 04/24/2003 | WO2002085295A3 Methods and compositions for the modulation of biofilm formation |
| 04/24/2003 | WO2002074959A3 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1 |
| 04/24/2003 | WO2002072822A3 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 04/24/2003 | WO2002071841A3 Methods for the identification of inhibitors of argininosuccinate synthase expression or activity in plants |
| 04/24/2003 | WO2002068695A3 Quantitative immunohistochemistry (qihc) |
| 04/24/2003 | WO2002066626A3 Regulation of human mut/nudix nucleoside triphosphate pyrophosphohydrolase |
| 04/24/2003 | WO2002066507A3 Histidine phosphatase interacting protein of 120 kd |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | WO2002057483A3 Method of identifying modulators of nogo-functions |
| 04/24/2003 | WO2002055710A3 Regulation of human purple acid phosphatase |
| 04/24/2003 | WO2002049576A9 Fab i and inhibition of apicomplexan parasites |
| 04/24/2003 | WO2002048392A3 Screening method for inhibitors of pyruvate orthophosphate dikinase |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002043741A3 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 04/24/2003 | WO2002042496A3 Methods and devices for characterizing duplex nucleic acid molecules |
| 04/24/2003 | WO2002042495A3 Method of screening eukaryotes |
| 04/24/2003 | WO2002034952A3 Screening assays |
| 04/24/2003 | WO2002034937A9 Methods for detection of differences in nucleic acids |
| 04/24/2003 | WO2002030980A3 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | WO2002018651A3 Methods for detecting papillomavirus dna in blood plasma and serum |
| 04/24/2003 | WO2002018585A8 Packaging of positive-strand rna virus replicon particles |
| 04/24/2003 | WO2002016615A3 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 04/24/2003 | WO2002014554A3 The anti-neoplastic agent et-743 inhibits trans activation by sxr |
| 04/24/2003 | WO2002012447A3 Isolation and use of solid tumor stem cells |
| 04/24/2003 | WO2002010446A3 Method for determining a partial nucleotide sequence of a nucleic acid molecule |
| 04/24/2003 | WO2002004513A3 Down syndrome critical region 1-like 1 proteins |
| 04/24/2003 | WO2002002225A3 Single molecule sequencing method |
| 04/24/2003 | WO2001098540A3 Recombination modulators and methods for their production and use |
| 04/24/2003 | WO2001086000A3 Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder |
| 04/24/2003 | WO2001083821A3 Polynucleotide probes for detection and quantitation of candida species |
| 04/24/2003 | WO2001078796A3 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 04/24/2003 | WO2001077389A3 Genes expressed in foam cell differentiation |
| 04/24/2003 | WO2001075440A3 Schizophrenia related genes |
| 04/24/2003 | WO2001071030A3 Genetic determinant for chronic inflammatory disease |
| 04/24/2003 | US20030079237 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 04/24/2003 | US20030079236 Polymorphisms associated with internalizing disorders |
| 04/24/2003 | US20030078736 Methods for generating differential profiles by combining data obtained in separate measurements |
| 04/24/2003 | US20030078405 47 human secreted proteins |
| 04/24/2003 | US20030078399 Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof |
| 04/24/2003 | US20030078396 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 04/24/2003 | US20030078389 Gamma-heregulin |
| 04/24/2003 | US20030078386 Antibody for use in the treatment of viral, gastrointestinal, autoimmune and cell proiferative disorders |
| 04/24/2003 | US20030078382 Human Ect2 and methods of use |
| 04/24/2003 | US20030078377 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 04/24/2003 | US20030078370 Antibodies to cyclin E2 protein |
| 04/24/2003 | US20030078222 Human receptor tyrosine kinase |
| 04/24/2003 | US20030078221 Method for treating a Complement System-mediated disease comprising administering a pharmaceutically effective amount of a Nucleic Acid Ligand of a Complement System Protein; SELEX method |
| 04/24/2003 | US20030078220 Invention provides genetic variants of the human Interleukin 4 Receptor Alpha (IL4R alpha ) gene and methods for identifying which variants of this gene are possessed by an individual |
| 04/24/2003 | US20030078219 Compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 2; cancer therapy |
| 04/24/2003 | US20030078202 Receptor derived peptides involved in modulation of response to ligand binding |
| 04/24/2003 | US20030078199 Human EphA6 gene and polypeptide |
| 04/24/2003 | US20030078191 OrfE is protein of kil gene of bacteriophage; ZipA is protein obtained from Escherichia coli; for inhibition of cellular proliferation |
| 04/24/2003 | US20030078188 Altering the conformation of the cytoplasmic kinase domain; drug screening; combinatorial chemistry |
| 04/24/2003 | US20030078187 For inhibiton of invasion of a host by a fungus; gene exression inhibition |
| 04/24/2003 | US20030077826 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC) |
| 04/24/2003 | US20030077824 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery |
| 04/24/2003 | US20030077817 Microfermentor device and cell based screening method |
| 04/24/2003 | US20030077808 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer |
| 04/24/2003 | US20030077805 Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof |
| 04/24/2003 | US20030077802 Human PRL1 phosphatase |
| 04/24/2003 | US20030077792 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077791 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077790 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |